Familial Chylomicronemia Syndrome (FCS) (HLP Type I)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Familial Chylomicronemia Syndrome (FCS) (HLP Type I) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

TerminatedPhase 3

NCT01589237

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Sy…

This study was to determine long-term safety and tolerability, and continued efficacy in lowering triglycerides of LCQ908 in subjects with Familial Chylomicrone…

United States, Canada, France38 participantsStarted 2013-02

Treatment: LCQ908

CompletedPhase 3

NCT01514461

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects W…

The purpose of this study is to determine whether LCQ908 is effective and safe in lowering triglycerides in subjects with Familial Chylomicronemia Syndrome (FCS…

United States, Canada, France45 participantsStarted 2012-07

Treatment: LCQ908, Placebo